A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents
Brief description of study
This is an observational study to determine what types of medications patients take to treat MCL as well as how patients respond to those medications.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Mantle Cell Lymphoma
-
Age: Between 18 Years - 99 Years
-
Gender: All
Male and Female 18 years of age and older DX of Mantle Cell Lymphoma
Updated on
22 Sep 2021.
Study ID: 832604
